Edition:
United States

Female Health Co (FHCO.OQ)

FHCO.OQ on NASDAQ Stock Exchange Capital Market

1.12USD
7 Dec 2016
Change (% chg)

$0.02 (+1.82%)
Prev Close
$1.10
Open
$1.12
Day's High
$1.17
Day's Low
$1.10
Volume
53,459
Avg. Vol
15,112
52-wk High
$2.74
52-wk Low
$0.74

FHCO.OQ

Chart for FHCO.OQ

About

The Female Health Company is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men's and women's health and oncology. The Company is engaged in the development, manufacture and marketing of consumer healthcare products. The Company has three divisions: Pharmaceutical and Devices,... (more)
No analyst recommendations are available for FHCO.OQ.

Overall

Beta: 1.34
Market Cap(Mil.): $31.96
Shares Outstanding(Mil.): 29.05
Dividend: --
Yield (%): --

Financials

  FHCO.OQ Industry Sector
P/E (TTM): 11.44 58.89 40.41
EPS (TTM): 0.10 -- --
ROI: 8.21 10.76 59.88
ROE: 8.24 16.88 67.66

BRIEF-Female Health Co says BMO Harris Bank approves to maintain $10 mln credit facility

* The Female Health Company / Veru Healthcare announces that BMO Harris Bank, N.A. approves amendment to maintain existing $10 million credit facility

Nov 29 2016

BRIEF-The Female Health Co says plans to launch Preboost in U.S. before year-end

* The Female Health Company / Veru Healthcare reports interim analysis of independent placebo controlled clinical study of Preboost, its proprietary premature ejaculation medication

Nov 17 2016

BRIEF-Female Health Co further adjourns special shareholders meeting to Oct 14

* Special meeting of shareholders scheduled for today has been adjourned to Friday, October 14, 2016

Sep 22 2016

BRIEF-The Female Health Co announces adjournment of special meeting of shareholders

* The Female Health Company announces adjournment of special meeting of shareholders to September 22, 2016

Sep 20 2016

BRIEF-Female Health and Aspen Park announce FDA clears pathway for expedited development of proprietary drug

* Female Health Company and Aspen Park Pharmaceuticals announce FDA clears pathway for expedited development of proprietary drug

Aug 17 2016

BRIEF-The Female Health Company reports fiscal 2016 third quarter results

* The Female Health Company reports fiscal 2016 third quarter and first nine months operating results

Jul 28 2016

Earnings vs. Estimates